Abbott Receives CE Mark for Next-Generation Navitor TAVI System to Treat Aortic Stenosis
Shots:
- Abbott has received CE Mark for Navitor making the minimally invasive device available for people in Europe with severe aortic stenosis who are at high or extreme surgical risk
- Navitor uses Abbott’s FlexNav delivery system along with a unique design for preventing blood leaking around the valve to provide a less invasive alternative to surgical aortic valve replacement. The device features a NaviSeal fabric cuff that works as with the cardiac cycle to eliminate the backflow of blood around the valve (PVL)
- The Navitor valve paired with the FlexNav delivery system streamlines and simplifies TAVI procedures for physicians
Ref: Abbott | Image: Media Post
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com